Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients

Abstract

NA to treatment and follow-up regimens is a common problem in the management of patients with AMD and DME and limits clinical treatment outcomes under real-life conditions. Patients with DME have the highest risk of patient-associated NA, associated with a higher risk for significant VA loss.